Triple Therapy for Cystic Fibrosis

October 18, 2018- interviewed by Steven E. Greer, MD

This entry was posted in - Biotech, - NEJM, - Pharma, FDA, Genetics, Infectious disease, Internal Medicine, National Jewish Health, Pediatrics, Pulmonology. Bookmark the permalink.

Leave a Reply